Aktis Oncology is aiming to bring in $182 million—or more—from what looks set to be the first biotech IPO of 2026. | Aktis ...
Aktis Oncology, Inc. targets $200M IPO to advance radiopharmaceuticals for solid tumors. Click for more on the upcoming AKTS ...
Pharmaceutical Technology on MSN
Aktis Oncology kicks 2026 IPO cycle off with $210m target
According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback